Free shipping on all orders over $ 500

 About 1 result found for searched term "GZD824 Dimesylate" (0.129 seconds)

Cat.No.  Name Target
M2749 GZD824 Dimesylate Src-bcr-Abl
Olverembatinib Dimesylate
GZD824 is a third-generation oral effective BCR-ABL inhibitor, acting on BCR-ABL (WT) and BCR-ABL (T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.